Sunday, December 3, 2023
As the most common progressive joint disorder in the United States, osteoarthritis affects 13.9% of adults aged 25 years and older and 33.6% of those older than 65 years, with an increasing prevalence because of an aging population. In addition, acute and chronic pain remains poorly managed, with many patients receiving ineffective or inappropriate analgesia, along with well-publicized findings showing that opioid analgesics are often overprescribed. This page provides education on the safety and efficacy of OTC pharmacotherapies for pain and practical considerations for their effective use in osteoarthritis and other inflammatory conditions.
An expert panel discussion onbest practices for the use of nonsteroidal anti-inflammatory drugs in patients with osteoarthritis.
Drs Clauw and Clarke discuss ways to help keep patients from transitioning to chronic pain.
Drs Stanos, Chou, and Pergolizzi discuss the integration of therapies to treat your patients with low back pain.
How do you manage pain in patients with primary dysmenorrhea?
Understanding NSAIDs: What are the CV risks?
Advance your skills in managing chronic pain using non-opioid analgesics
Dr Angiolillo reviews the pharmacology of NSAIDs and selecting the appropriate agent for the management of pain.